Comparative study of proton and phosphorus magnetic resonance spectroscopy in schizophrenia at 4 Tesla

被引:15
作者
Théberge, J
Al-Semaan, Y
Jensen, JE
Williamson, PC
Neufeld, RWJ
Menon, RS
Schaefer, B
Densmore, M
Drost, DJ
机构
[1] London Hlth Sci Ctr, Dept Psychiat, London, ON N6A 5A5, Canada
[2] Univ Western Ontario, Dept Med Biophys, London, ON, Canada
[3] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia
[4] Harvard Univ, McLean Hosp, Dept Psychiat, Brain Imaging Ctr,Med Sch, Belmont, MA 02178 USA
[5] Univ Western Ontario, Dept Psychol, London, ON, Canada
[6] Robarts Res Inst, London, ON N6A 5C1, Canada
基金
加拿大健康研究院;
关键词
schizophrenia; spectroscopy; phosphorus; proton; phospholipid metabolism; high field; neurodegeneration;
D O I
10.1016/j.pscychresns.2004.08.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study used high-field magnetic resonance spectroscopy to examine the correlation of 1H and 31P metabolite levels in patients with schizophrenia and normal controls. 1H and 31P in vivo spectra were acquired successively from the left anterior cingulate and left thalamus of nine chronic schizophrenic patients and eight comparable healthy controls. A significant positive correlation between glutamine (Gln) and phosphoethanolamine (PEtn) was found in the left anterior cingulate of patients. In the left thalamus of patients, a significant negative correlation between N-acetylaspartate (NAA) and glycerophosphocholine (GroPCho) was found. No significant correlations were found in controls. The correlation between glutamine and phosphoethanolamine may reflect a link between neurotransmission alterations and membrane phospholipid metabolism alterations. The negative correlation between N-acetylaspartate and glycerophosphocholine may reflect the presence of neurodegeneration. © 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 39 条
  • [11] A glutamatergic deficiency model of schizophrenia
    Carlsson, A
    Hansson, LO
    Waters, N
    Carlsson, ML
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 : 2 - 6
  • [12] First M.B., 2007, STRUCTURED CLIN INTE
  • [13] INCREASED PLASMA PHOSPHOLIPASE-A2 ACTIVITY IN SCHIZOPHRENIC-PATIENTS - REDUCTION AFTER NEUROLEPTIC THERAPY
    GATTAZ, WF
    KOLLISCH, M
    THUREN, T
    VIRTANEN, JA
    KINNUNEN, PKJ
    [J]. BIOLOGICAL PSYCHIATRY, 1987, 22 (04) : 421 - 426
  • [14] AUTOMATIC, LOCALIZED INVIVO ADJUSTMENT OF ALL 1ST-ORDER AND 2ND-ORDER SHIM COILS
    GRUETTER, R
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1993, 29 (06) : 804 - 811
  • [15] Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases
    Hoang, TQ
    Dubowitz, DJ
    Moats, R
    Kopyov, O
    Jacques, D
    Ross, BD
    [J]. NEUROLOGY, 1998, 50 (04) : 1033 - 1040
  • [16] JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301
  • [17] In vivo brain 31P-MRS:: measuring the phospholipid resonances at 4 Tesla from small voxels
    Jensen, JE
    Drost, DJ
    Menon, RS
    Williamson, PC
    [J]. NMR IN BIOMEDICINE, 2002, 15 (05) : 338 - 347
  • [18] Region-specific changes in phospholipid metabolism in chronic, medicated schizophrenia -: 31P-MRS study at 4.0 Tesla
    Jensen, JE
    Al-Semaan, YM
    Williamson, PC
    Neufeld, RWJ
    Menon, RS
    Schaeffer, B
    Densmore, M
    Drost, DJ
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2002, 180 : 39 - 44
  • [19] JENSEN JE, 2002, P INT SOC MAGN RES M
  • [20] KE Y, 2000, P INT SOC MAGN RES M